Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision note (v3.4.3) was added, and several related topics including Type 2 diabetes, MedlinePlus Genetics, and the previous revision reference (v3.4.2) were removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:17:46.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added related topics MedlinePlus Genetics and Type 2 diabetes for additional context, without altering the study's core information.
    Difference
    0.1%
    Check dated 2026-03-04T14:16:49.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics' from the related topics section. This alters the visible topic signals and may affect discoverability for users seeking information on type 2 diabetes and related genetics resources.
    Difference
    0.1%
    Check dated 2026-02-25T10:43:44.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T05:49:42.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding lapse notice was added, noting possible delays and directing readers to cc.nih.gov and opm.gov for status updates. The page revision changed from v3.4.0 to v3.4.1 and added related topics such as Type 2 diabetes and MedlinePlus Genetics.
    Difference
    0.4%
    Check dated 2026-02-04T04:31:09.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata fields to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a revision note 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or updated accordingly.
    Difference
    0.1%
    Check dated 2026-01-28T02:38:34.000Z thumbnail image

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.